Resverlogix Corp (RVXCF) 2.1400 $RVXCF Seeking Alpha's

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Resverlogix Corp (RVXCF) 2.1400 $RVXCF

Seeking Alpha's Biotech Weekly: A Biogen Deep Dive, Eisai's Arena Shuffle, And More
SA Editor Mike Taylor - at Seeking Alpha - Fri Apr 10, 3:00PM CDT
Every Friday, Seeking Alpha's Biotech Weekly highlights the editors' picks of the week's Seeking Alpha analysis, as well as a review of the top Breaking News stories. See something here that deserves further analysis? We are always looking for new...
BIIB: 425.65 (-0.98), SPHS: 0.67 (+0.01), ADMS: 17.94 (+0.80), TKMR: 18.19 (+0.59), CBYL: 5.29 (-0.27), HPTX: 45.79 (-0.01), QURE: 28.44 (-2.35), SHPG: 248.77 (-5.55), SRPT: 13.85 (-0.21), HZNP: 28.48 (+1.16), GALE: 1.38 (-0.02), JUNO: 60.39 (+1.15), ABBV: 62.00 (+1.68), CBMG: 28.95 (+1.47), ARNA: 4.55 (+0.01), EXEL: 3.04 (+0.03), ADXS: 19.73 (+0.86), PTLA: 38.79 (+0.75), BMY: 64.64 (+1.18), OCUL: 26.99 (-1.55), NVO: 55.94 (+1.34), DVA: 81.90 (+0.38), HALO: 15.43 (+0.17), GILD: 101.77 (+0.61), MRK: 57.25 (-0.18), AZN: 69.91 (-0.25), ALXN: 182.68 (+5.31), NVS: 103.58 (+1.01)

Analysis Of The Science Behind RVX-208
Bjarke Krysel Christensen - at Seeking Alpha - Wed Apr 08, 8:25AM CDT

AZN: 69.91 (-0.25)

Resverlogix Receives Two Patents for RVX-208 in China
PR Newswire Europe - Tue Apr 07, 6:31AM CDT
CALGARY, Alberta, April 7, 2015 /PRNewswire/ --
RVX.TO: 2.72 (+0.63)

Resverlogix Presents at the Prestigious American College of Cardiology 64th Annual Scientific Session & Expo (ACC.15)
PR Newswire - Mon Mar 16, 12:30PM CDT
RVX-208 the first selective bromodomain extra-terminal (BET) protein inhibitor being developed for patients with high residual risks of cardiovascular disease
RVX.TO: 2.72 (+0.63)

Resverlogix Presents at Biotech Showcase During JP Morgan Week
PR Newswire - Wed Jan 14, 7:00PM CST
Resverlogix Corp. (TSX:RVX) (the "Company" today announced that Donald McCaffrey, president and chief executive officer presented at the 7th Annual Biotech Showcase Conference 2015 during JP Morgan week. The presentation can be accessed via the following link: http://edge.media-server.com/m/p/5wz2z9gn
RVX.TO: 2.72 (+0.63)

Resverlogix Names Michael Sweeney, M.D., as Senior Vice President of Clinical Development
PR Newswire - Mon Nov 03, 4:05PM CST
Resverlogix Corp. (TSX:RVX) today announced the appointment of Michael T. Sweeney, M.D., as senior vice president of clinical development.
RVX.TO: 2.72 (+0.63)

Resverlogix Corporate Update Conference Call & Webcast Announcement
PR Newswire - Wed Oct 01, 1:00PM CDT
TSX Exchange Symbol: RVX
RVX.TO: 2.72 (+0.63)

Resverlogix Corp. Closes Additional $30 million from Citibank Loan
PR Newswire - Fri Aug 15, 4:00PM CDT
TSX Exchange Symbol: RVX
RVX.TO: 2.72 (+0.63)

Resverlogix Corp. Shareholders Approve Additional $30 million from Citibank Loan
PR Newswire - Wed Aug 13, 4:01PM CDT
TSX Exchange Symbol: RVX
RVX.TO: 2.72 (+0.63)

Restenosis - Pipeline Review, H1 2014
M2 - Fri Jun 27, 5:13AM CDT
Research and Markets (http://www.researchandmarkets.com/research/fzlqdr/restenosis) has announced the addition of the "Restenosis - Pipeline Review, H1 2014" report to their offering. This report provides comprehensive information on the therapeutic development for Restenosis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Restenosis and special features on late-stage and discontinued projects. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis. Reasons to buy - Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Develop strategic initiatives by understanding the focus areas of leading companies - Identify and understand important and diverse types of therapeutics under development for Restenosis - Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline - Devise corrective measures for pipeline projects by understanding Restenosis pipeline depth and focus of Indication therapeutics - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope - Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline Companies Mentioned: - Shire Plc - Resverlogix Corp. - CytoTools AG - Angelini Group - Viron Therapeutics, Inc. - AIM Therapeutics Inc. - CSPC NBP Pharmaceutical Co.,ltd - XBiotech USA, Inc. For more information visit http://www.researchandmarkets.com/research/fzlqdr/restenosis
SHPG: 248.77 (-5.55)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Saga Metals Advances Radar Project with HQ Drill Success

Updated Category News Views 141

Digging Deep at Trapper North: Saga's Strategic Drill Move There's nothing like the thrill of discovery, especially in the rough-and-tumble world of mining exploration. Saga Metals Corp., anchored deep in the critical minerals scene, has wrapped up an HQ-diameter drill program at its Radar Project, smack dab near Cartwright, Labrador. You hear 1,010 meters and maybe...

Continue Reading
Domino's in Hot Water? Fiduciary Duty Concerns Loom

Updated Category News Views 55

Shareholder Rights On The Line You ever get that itch, the one that whispers something's off with a company? Well, that itch might be turning into a rash at Domino's Pizza, Inc. (NASDAQ: DPZ). Shareholders are being nudged to jump into the fray as Halper Sadeh LLC investigates potential wrongdoings by some of the pizza titan's bigwigs. The spotlight is on whether these...

Continue Reading
Sunlife's Q3 2026: Mixed Signals Amid Solid Growth

Updated Category News Views 36

Strong Performance But Not Without Potholes Sunlife's latest earnings release for Q3 2026 paints a picture of a company riding high on strategic growth initiatives but stumbling on a few financial speed bumps. If you're tracking TSX:SLF, these quarterly numbers are a blend of sweet and sour. The company's underlying net income climbed to $1,146 million, up by $99 million...

Continue Reading
Union Pacific-Norfolk Southern Merger: A Game Changer?

Updated Category News Views 86

What's the Big Deal with This Merger? Take a hard look at the Union Pacific-Norfolk Southern merger, and you start to see numbers that could make any grizzled investor sit up and pay attention. This isn't just a boardroom shuffle—it’s about potentially giant leaps in economic and health benefits. William Michael Cunningham pulls no punches in his latest study. He puts...

Continue Reading
Jennifer Wills Takes Helm as Sole CEO of Kelleher

Updated Category News Views 175

Jennifer Wills Leads Kelleher International Forward There's a fresh breeze blowing through the halls of Kelleher International, the luxury matchmaking firm. Jennifer Wills, a savvy player with her roots in law and finance, has stepped up as the sole CEO. After a decade of busting her chops at the firm, it's high time she's taken the helm. This ain't just a job transition;...

Continue Reading
Youdao's Upcoming Q3 2026 Results: What's at Stake?

Updated Category News Views 67

Anticipation Builds Ahead of Youdao's Financial Announcement Okay, folks, if there's one thing investors gotta mark on their calendars, it's Youdao’s upcoming financial results set to drop like a bombshell on November 19, 2026. This ain't just another quarterly report—it's a litmus test for anyone eyeballing the digital learning sector with wallets ready. Youdao: A...

Continue Reading
Nomad Foods' Battle with Margins Amid Flat Volumes

Updated Category News Views 112

Subtle Winds of Change in Nomad Foods' Financials Ah, Nomad Foods—Europe's frozen food titan, trotting out its third quarter numbers like a well-rehearsed production line. You've got your slight revenue bump of 2.3% on reported streams, hitting €770 million. But dig a little deeper and you find organic revenue doing a waltz at 1.6% year-on-year, surprising no one...

Continue Reading
Dionisio Gutiérrez Honored by King Felipe VI in Madrid

Updated Category News Views 35

Recognition doesn’t come easy in the world stage, but when it does, it paints a picture of influence and dedication. That's where Dionisio Gutiérrez finds himself, under the lights and the grandeur that only a setting in Madrid can offer. On November 4th, he received the Enrique V. Iglesias Award, directly from King Felipe VI, a nod to Gutiérrez's impact in the...

Continue Reading
Crude Insight: Refining Margins Expand, LNG Orders Rise

Updated Category News Views 166

Refining Margins Stretch While LNG Orders Surge Well, folks, oil markets have sure been a rollercoaster lately. WTI futures danced all over the place, closing near $96 a barrel after brushing against both $93 and $99 earlier this week. Brent wasn't left out of the tango, setting at $103.60. Everyone's holding their breath each time these numbers come through. Energy...

Continue Reading
High School Interns Shine at SecurityBakeoff Project

Updated Category News Views 76

Teen Talent Takes Center Stage at QED Would you trust a group of high schoolers with your cybersecurity needs? Well, turns out it might not be such a bad idea. QED Secure Solutions has turned the spotlight on three brilliant young interns who are leading the charge on a project called SecurityBakeoff. It's not just another classroom exercise—these teens are creating...

Continue Reading

Top 5 Most Recently Viewed Articles

Unlocking Potential: Berlin’s Blockchain & AI Week 2025

Updated Category News Views 243

Embracing the Future: Berlin’s Role in Blockchain and AI As we look into the future, Berlin stands out as a vital player in the world of blockchain technology and artificial intelligence. The German Blockchain & AI Week 2025 will take place from June 12 to 19, a gathering designed to propel innovations and partnerships that will drive the digital economy. Understanding...

Continue Reading
Royal Cup Coffee and Tea Partners with U.S. Culinary Open

Updated Category News Views 161

Royal Cup Coffee and Tea Partners with U.S. Culinary Open Royal Cup Coffee and Tea is excited to announce its recent sponsorship of the esteemed U.S. Culinary Open. This feature event is part of the North American Food Equipment Manufacturers (NAFEM) Show, which will be held at the Georgia World Congress Center. Attendees can look forward to this exciting collaboration...

Continue Reading
Innovative Advancements in Liver Disease Treatments by Gyre

Updated Category News Views 108

Gyre Therapeutics Showcases Progress in Liver Disease Solutions Gyre Therapeutics, a leading biotechnology firm focused on chronic organ diseases, has reported impressive developments and financial results for its operations. As of late September, the company had achieved notable milestones in its clinical trials and product launches, demonstrating its commitment to...

Continue Reading
Exploring the $7.04 Billion SD-WAN Market Opportunity

Updated Category News Views 230

Unlocking the Potential of the SD-WAN Market In today’s fast-paced digital environment, organizations are constantly seeking ways to enhance their network infrastructures. This has resulted in the rapid growth of the Software-Defined Wide Area Network (SD-WAN) market, which is projected to reach a valuation of $7.04 billion by 2030, according to recent findings from...

Continue Reading
Michelle Fermin Earns Place in Century 21 Hall of Fame

Updated Category News Views 144

Michelle Fermin Inducted into the Hall of Fame In a remarkable recognition of her contributions to the real estate industry, Michelle Fermin from CENTURY 21 North East has been inducted into the prestigious Century 21 Dick Loughlin International Hall of Fame. This prestigious honor was announced during a recent Top Agent Retreat, showcasing her dedication and commitment...

Continue Reading